Takeda Offers Three New Drugs with Same Active Ingredient as Actos

After Winning FDA Approval for Actos’ Active Ingredient Alogliptin, Takeda Will Offer Three New Drugs After much back and forth with the FDA, Takeda Pharmaceuticals – the manufacturers of the controversial and dangerous Type 2 diabetes drug, Actos – have won approval for new formulations of the active ingredient alogliptin. Actos, the … [Read more...]

$9 Billion Actos Verdict Reduced

Judge Reduces Actos Award by 99.6% In April, a jury ruled that Takeda Pharmaceutical’s blockbuster Type 2 diabetes drug, Actos, was the cause of a plaintiff’s bladder cancer in a bellwether case representing many personal injury cases against the company. Plaintiff Terrence Allen and his wife alleged that the man took Actos as prescribed, and he … [Read more...]

Illinois Actos Injury Trial Goes to Takeda

Actos Injury Case in Illinois Decided in Favor of Takeda Pharmaceuticals Takeda Pharmaceuticals, the drug company behind Type 2 diabetes drug Actos, won their most recent personal injury lawsuit that alleged that Actos caused the plaintiff’s bladder cancer. On Thursday, May 15th, the 12-member jury in Chicago ruled that Actos was not responsible … [Read more...]

$6.5 Million Awarded to Victim in Actos Bladder Cancer Lawsuit

Bellwether Actos Trial Returns Verdict in Favor of Plaintiff, Wins Damages The first of more than 3,000 personal injury lawsuits against Takeda Pharmaceuticals has returned a verdict, in favor of the plaintiff. On Friday, April 26th, Jack Cooper was awarded $6.5 million in personal injury damages by a jury which ruled that Takeda … [Read more...]

Takeda to Resurrect Actos as Alzheimer’s Drug

Japanese Pharmaceutical Company Aims to Develop Lower-Dose Actos into Alzheimer’s Treatment Takeda Pharmaceuticals and their partner, Zinfandel Pharma, have started a Phase III trial of Actos – generically known as pioglitazone – in people who are at risk of developing Alzheimer’s disease. The phase III trial, known as the TOMMORROW trial, will … [Read more...]

BestLawyers.comAVBetter Business Bureau